HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

SILVERCREST ASSET MANAGEMENT GROUP LLC's Holding History (CIK: 0001232395)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 636,589 Value ($000) $36,438 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 603,631 Value ($000) $31,606 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 603,137 Value ($000) $24,536 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 591,332 Value ($000) $21,856 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 633,074 Value ($000) $24,183 Avg Close $40.96 Range $35.71 - $45.00
Q2 2023
Shares 516,170 Value ($000) $18,618 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 341,283 Value ($000) $13,034 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 412,640 Value ($000) $23,479 Avg Close $51.20 Range $39.17 - $59.46
Q3 2022
Shares 438,541 Value ($000) $17,340 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 383,854 Value ($000) $16,890 Avg Close $43.25 Range $36.95 - $48.58
Q1 2022
Shares 292,328 Value ($000) $11,658 Avg Close $35.62 Range $31.36 - $42.33
Q4 2021
Shares 8,758 Value ($000) $352 Avg Close $37.33 Range $31.79 - $41.20
Q3 2021
Shares 7,878 Value ($000) $320 Avg Close $41.81 Range $37.80 - $46.62
Q2 2021
Shares 6,960 Value ($000) $316 Avg Close $44.26 Range $38.65 - $51.57
Q1 2021
Shares 6,822 Value ($000) $284 Avg Close $45.65 Range $38.80 - $56.40
Q4 2020
Shares 6,601 Value ($000) $282 Avg Close $35.95 Range $25.70 - $44.53